How much of your cash is genuinely surplus once the operating plan, committed investment, a sensible buffer and covenant requirements are all provided for. Management teams routinely over-reserve, and the real number tends to surprise.
Whether repurchasing stock is the right use of surplus capital at your valuation, what size of programme your liquidity can actually absorb, and how the market is likely to read the decision.
Special versus common, initiation versus increase, and what each commits you to in the years that follow. A regular dividend brings in a particular kind of holder and is painful to walk back.
Where you sit against your covenants, how much headroom you genuinely hold, and whether deleveraging is a better use of capital than returning it. Often the least exciting answer and the correct one.
What your funding actually costs you against comparable businesses, and which parts of your debt-equity mix are responsible for any difference.
Each option run against your risk tolerance and a range of market conditions, so the board sees what happens if rates move, conditions tighten or the plan underdelivers.
Not deciding is itself a decision, and it is the one shareholders notice. A stated policy is worth more than a large balance with no explanation attached to it.
An investor, or several, have raised it directly. You need an independent position before that conversation goes any further.
Conditions have moved since the facility was agreed, and the headroom needs establishing properly rather than estimated.
We fix the numbers everyone is arguing about: surplus capital, covenant headroom, real debt capacity.
Your cost of capital and debt-equity mix set against comparable businesses, with the gaps explained.
Buyback, dividend and deleveraging run side by side against your risk tolerance and a range of conditions.
A course of action you can take to the board, presented with the counter-argument rather than without it.